Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate augmentation in treatment-resistant generalized social phobia
NCT00182455Phase 4Terminated
- Sponsor
- McMaster University
- Start
- Mar 2004
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing Topiramate + SSRI with Placebo + SSRI (2 arms). Primary endpoints: Clinical Global Impression - Improvement at 12 weeks and Liebowitz Social Anxiety Scale at 12 weeks. Started Mar 2004; status: terminated.
02
Drugs
topiramate
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00182455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182455.